Faecal microbiota transplantation in patients with Clostridium difficile and significant comorbidities as well as in patients with new indications: A case series

Table 2 The results of fecal microbiota transplantation treatments of eight patients with different new indications

	Patient and diagnosis	Age at 1st FMT and gender	Route of administration	Outcome	FMT related complications
1	A carrier of Salmonella #1	17-year-old male	Colonoscopy	Successful eradication of Salmonella	No
2	A carrier of Salmonella #2	52-year-old female	Colonoscopy	Successful eradication of Salmonella	No
3	A patient with TMAU #1	24-year-old male	Gastroscopy	Moderate self-reported benefit up to 6 mo, at 12 mo symptoms had recurred to former severity	No
4	A patient with TMAU #2	49-year-old female	Gastroscopy	No change in self-reported symptom severity	No
5	A patient with SIBO	66-year-old male	Gastroscopy	Self-reported decrease in symptom severity	No
			(treated 3 times using 2 donors)
6	A patient with lymphocytic colitis	21-year-old female	Colonoscopy	Two week decrease in self-reported symptoms, then recurrence of symptoms to former severity	No
7	A carrier of norovirus	32-year-old female	Colonoscopy	No change in self-reported symptom severity, no success in virus eradication	No
8	A carrier of ESBL-producing	31-year-old female	Colonoscopy	Successful eradication of ESBL-producing E. coli	No

FMT: Fecal microbiota transplantation; TMAU: Trimethylaminuria; SIBO: Small intestinal bacterial overgrowth; E. coli: Escherichia coli.